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ABSTRACT. The use of hydrophilic central venous catheters, 
percutaneously inserted by means of the Seldinger technique, 
was evaluated in this prospective study. Between 1988 and 
1991, 138 catheters were inserted in newborns who were 
admitted to our neonatal intensive care unit. An adequate 
position of the tip, evaluated radiographically, was achieved 
in 130 (94.2%) of these insertions. The side effects associated 
with these 130 catheters and the duration of their use were
recorded. Results were compared with those of percutaneously 
inserted Silastic catheters described in the literature. The rate 
of adequate catheter placement seems comparable. Because 
of a high rate of minor mechanical complications, the mean 
catheter duration was rather short (8.3 days). However, the 
incidence of serious complications, especially infectious 
complications, was low. (Journal of Parenteral and Enteral 
Nutrition 19:151-155, 1995)
Long-term central venous access is an essential part 
of the care of sick (especially preterm ) newborns.1 In 
neonatal intensive care units, the percutaneous insertion 
of a small Silastic central venous catheter via a peripheral 
vein, as initially described by Shaw ,2 is used most 
frequently. The catheter’s small outer diameter (0,6-0.635 
mm) and low thrombogenicity result in appropriate mean 
catheter durations (7.9 to 25.4 days). The rates of serious 
complications such as sepsis (0% to 12.5%) and 
thrombosis (0% to 1.6%) are low in most studies/*“10 
Introduction of the catheter is easy, and high success 
rates have been described. Insertion can be done while 
the patient is on the ward, thus saving time and money.11 
However, it is known that Silastic catheters have some 
disadvantages. Their small internal diameter limits the 
flow rate. The poor tensile strength is a potential risk 
for catheter rupture during flushing or removal/ 2 
especially if the catheter becom es lodged in the vein 
wall.1“ Because of its flexibility, the catheter could be 
difficult to advance through the axillary or inguinal 
region. Moreover, the catheter can become occluded 
more easily as a consequence of rotation.
A possible alternative is a polyurethane catheter, which 
is made hydrophilic by applying a hydromer coating. 
This material is less thrombogenic than Silastic1,5 and 
is known to resist bacterial adhesion .15 Its greater tensile 
strength minimizes the risk of catheter rupture or 
rotation, and its relatively large internal diameter permits 
higher flow rates. The use of the Seldinger technique10
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makes appropriate positioning easy to achieve. Venous 
access can be gained with a small-bore needle before 
insertion of the larger catheter. Vascular injury at the 
insertion site, an important etiologic factor for compli­
cations, is thus diminished. The risk of catheter embolus, 
secondary to shearing with the insertion needle, is also 
eliminated.
Our experience with the insertion of a hydrophilic 
polyurethane central venous catheter by means of the 
Seldinger technique is described in this prospective 
study. The duration of catheter use in newborns and 
the complications associated with its use were also 
evaluated. Results were compared with those of 
percutaneously inserted Silastic central venous catheters 
described in the literature.
PATIENTS AND METHODS
In the interval from March 1988 until May 1991, 138 
hydrophilic polyurethane catheters (Iiydrocath, Ohmeda, 
BOG Group, Windlesham, UK) were inserted in 110 
newborns by means of the Seldinger technique. A single 
catheterization was performed in 94 newborns, two were 
performed in 13 newborns, three were performed in 
two newborns, and four were necessary in one newborn. 
Some demographic data of these newborns are shown 
in Table I.
Introduction of the central venous catheter was 
indicated when prolonged parenteral nutrition (more 
than 3 days) was expected or when intravenous access 
was still necessary after peripheral sites were exhausted. 
The catheters had an outer diameter of 20 or 22 gauge 
(1.1 and 0,9 mm, respectively) and allowed maximal 
flow rates of 17 and 14 mL/minute, respectively. The 
10-cm-long, 22-gauge catheter was commonly used. In 
larger infants (weight more than 2500 g), this length
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was insufficient to  reach an adequate tip location, and 
the 20-cm-long, 20-gauge catheter was used.
Catheters were inserted percutaneously through a 
peripheral vein. The most suitable peripheral vein for 
this technique is the medial antecubital (basilic) vein. 
Additional suitable sites include the axillary,17 greater 
saphenous, right preauricular scalp vein, and lateral 
antecubital (cephalic) vein. An aseptic technique is 
essential during the procedure. Infants were positioned 
(and physically restrained by an assistant) to expose 
the insertion site. No local anesthetic was applied. A 
thin-walled, 24-gauge IV cannula (Insyte, Becton Dick­
inson, Utah, USA) was inserted into the peripheral vein. 
The straight end of the guide wire was advanced gently 
through the cannula as far as possible. After positioning 
the guide wire, the IV cannula was withdrawn, and the 
central venous catheter was introduced over the guide 
wire and gently advanced. Previous widening of the 
sldn entry site with a blood lancet made the introduction 
easier. If resistance was encountered, the catheter was 
withdrawn for 1 cm and then advanced under gentle 
manipulation of the extremity. If further advance was 
still impossible, the J-shaped end of the guide wire was 
introduced through the catheter. An attempt was made 
to advance the guide wire with some rotation. When 
the cardiorespiratory monitor showed abnormal electro­
cardiogram complexes, the tip was presumed to be in 
the atrial cavity; the wire was partly withdrawn, and 
the catheter was advanced to reach a proper position. 
Intraluminal position of the central venous catheter was 
confirmed by free aspiration of blood and flushing 
through the catheter. The hub of the central venous 
catheter was fixed to the sldn with adhesive tape. The 
skin entry site was covered with a small piece of 
nonocclusive gauze, which was fixed to the sldn with 
adhesive silk tape. The joint nearest tire insertion site 
was splinted. Other movements of the newborn’s limb 
were not restricted.
Tip location was verified radiographically. In case of 
misplacement (crossing over/opposition of flow direc­
tion), the catheter was repositioned. A catheter was 
defined as central when the tip was in the innominate 
vein, the superior/inferior caval vein, or the right atrial 
cavity. When the tip was in the subclavian or common 
iliac vein, it was defined as semicentral. If the tip of 
the catheter remained peripheral, the administration of 
parenteral nutrition or hyperosmolar solutions was not 
allowed. No further analysis of duration of catheter use 
and associated side effects was performed on this group.
The central venous catheter was used for the 
administration of parenteral nutrition or medication. If 
no other venous access was available, red-cell concen­
trates were also infused through it. Infusion of platelet 
concentrates was not permitted.
A volumetric infusion pump (Terumo, Terumo Corp, 
Tokyo) maintained a continuous flow (at least 2 m l/h) 
of a 10% dextrose solution. Heparin was added in a 
dose of 2 IU/h to prevent clot formation. No millipore 
filters were used.
The nonocclusive dressing was changed daily, and 
Mupirocine (Bactroban, Beecham Pharmaceuticals,
T a ble  I
Demographics of the newborns in whom central venous catheters were
inserted (n = 130)*
Mean Range
Actual weight (g) 1383.6 (490-4060)
Gestational age (wk) 30.5 (24-41)
Age at insertion (d) 12.0 (0-136)
Admission in neonatal intensive care unit (d) 46.2 (0-197)
* Male:female, 65:45,
Brenthford, UK) ointment was applied at the sldn entry 
site. A nurse checked the position of the catheter 
(torsion, kinking, or displacement) and the aspect of 
the extremity (redness, swelling, tenderness, or the 
presence of a palpable venous cord). If any abnormality 
was observed, a neonatologist decided whether the 
catheter should be removed or if it should remain in 
place. Catheters were removed for the following reasons: 
(1) termination of parenteral nutrition/IV therapy; (2) 
death of the newborn; (3) suspicion of catheter-related 
sepsis; (4) obstruction (unrestorable); (5) thrombophle­
bitis (appearance of two or more of the following signs: 
pain, erythema, swelling, induration, or a palpable venous 
cord)18; (6) extravasation (isolated swelling of a  limb 
without redness or dilated veins); (7) perforation 
(infusion into an extravascular cavity); (8) fluid leak 
from the insertion site; or (9) accidental dislodgment.
If clinical signs of sepsis were apparent, blood cultures 
were taken peripherally and through the catheter, and 
antibiotic therapy was started. When both cultures 
revealed the same organism, catheter-related sepsis was 
confirmed. When the culture drawn from the catheter 
was positive and the peripheral culture was negative, 
it was considered to be catheter colonization. li),2° The 
catheter was removed in both cases. If only the peripheral 
culture was positive, the catheter remained in place. In 
all cases, antibiotic therapy was actfusted to the sensitivity 
of the organism.
In the case of obstruction, the catheter was gently 
flushed with a saline solution. If the flushing was 
unsuccessful, a  sufficient amount of urokinase (2500 
U/mL) was incubated in its lumen. Aspiration was 
attempted after 3 hours .21 If patency was not restored 
and thrombosis was excluded by ultrasonography ,22,2:1 
the catheter was removed.
The presence of thrombosis was routinely checked 
by ultrasonography before catheter removal. If throm ­
bosis was revealed, the catheter remained in place, and 
fibrinolytic therapy was started (urokinase: loading dose, 
4400 U/kg in 10 minutes; maintenance dose, 4400 U/kg/h; 
adjustments on the basis of the thrombin time),2'1,25 A 
routine bacteriologic culture of the tip was taken at 
removal.
RESULTS
Central venous catheter placement was successful if 
the tip was in a central or semicentral position. This 
was achieved in 94.2% of the introductions. (Table II)
In eight cases (5.8%) the catheter tip remained 
peripheral. Six of the eight were due to problems in 
passing the axillary region which occured three times
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in the Basilic as well as cephalic vein. In two cases, a 
catheter inserted in the cephalic vein went distally 
through the basilic vein. The misplacement rates were 
3.7% and 10.7%, respectively, for the basilic and cephalic 
vein. When the greater saphenous vein was used, the 
catheter tip usually reached a semicentral position 
because of the longer route in relation to the catheter 
length.
The rate of centrally positioned catheter tips decreased 
as birth weight increased. The group with birth weights 
greater than 2500 g was an exception because 20-cm- 
long, 20-gauge catheters were used in some of the 
newborns; a  central position was achieved in all six 
placements. The use of the 10-cm long, 22-gauge catheter 
in this same birth weight group resulted in misplacement 
two times, in a semicentral position six times, and in 
a central position just two times (Table III),
The central venous catheters remained in place for 
a total of 1073 days. Mean catheter duration was 8.3 
days (range, 0 to 36 days). Thirty-four catheters (26.2%) 
were removed electively (Table IV),
Twenty-four newborns died with catheters in place. 
None of the deaths were catheter-related. Catheters 
were removed 68 times because of minor complications 
such as obstruction, thrombophlebitis, extravasation, 
dislocation, or fluid leakage. Major complications such 
as thrombosis, sepsis, or perforation necessitated cathe­
ter withdrawal in four cases. Thrombosis was treated 
with urokinase via the same catheter in accordance 
with our protocol. In one case, however, the thrombus 
influenced catheter patency to such an extent that the 
catheter had to be removed.
Although it resulted in catheter withdrawal only once, 
thrombosis was seen as a complication five times (3,8%). 
The central venous catheter was removed twice after 
successful urokinase therapy. One newborn died because 
of a congenital cardiac anomaly soon after detection of 
the thrombus. The reasons for removal, which were 
recorded in these cases, were “elective” and “death,” 
respectively. In one case, ultrasonography showed no 
signs of a thrombus, and the reason for removal of the 
central venous catheter was noted as thrombophlebitis. 
Two days later a thrombus was demonstrated by 
phlebography in the superior caval vein.
Two central venous catheters inserted into the left 
saphenous and right basilic vein, respectively, perforated 
into a cavity. In the first case, a  local swelling and 
decreased peristaltic activity, which did not interfere 
with the clinical condition, were observed. A contrast 
radiographic study revealed contrast collection in the 
retroperitoneal cavity. In the second case, the newborn 
became dyspneic and had to be resuscitated because 
of bradycardia 30 hours after the central venous catheter 
was inserted. The chest x-ray led us to suspect pleural 
effusion; some atelectatic places were evident. The 
newborn recovered about 4 days after the central venous 
catheter was withdrawn and a  thoracic drain (yellow 
fluid) was inserted.
One episode of catheter-related sepsis was seen in 
1073 catheter days (0,9 episodes per 1000 days). Tip 
cultures and peripherally drawn cultures both revealed
T able  II
Position* of central venous catheter reached from insertion sites
Insertion
(vein)
Central Semic entrai 
n (% row)
Malposition Total 
n (% column)
Basilic 46 (56.8) 32 (39.5) 3 (3.7) 81 (58.7)
Cephalic 15 (53.6) 10(35.7) 3 (10.7) 28 (20.3)
Axillary 7 (77.8) 2 (22.2) 0 (0.0) 9 (6.5)
Saphenous 5 (29.4) 11 (64.7) 1 (5.9) 17 (12.3)
Scalp 2 (66.6) 0 (0.0) 1 (33.3) 3 (2.2)
All 75 (54,3) 55 (39.9) 8 (5.8) 138 ('100.0)
* A catheter was defined as central when the tip was in the innominate 
vein, the superior/inferior caval vein, or the right atrial cavity. When the 
tip was in the subclavian or common iliac vein, it was defined as semicen­
tral.
T able  III
Position* of the central venous catheter in relation to weight of newborn
Weight (g) Central Semicentral n (% row) Malposition
Total 
n (% column)
<1000 43 (68.3) 16 (25.4) 4 (6.3) 63 (45,7)
1000-1500 14 (51.9) 13 (48.1) 0 (0.0) 27 (19.6)
1500-2000 6 (27.3) 14 (63.6) 2 (9.1) 22 (15.9)
2000-2500 4 (40.0) 6 (60.0) 0 (0.0) 10 (7.2)
> 2500 8 (50,0) 6 (37.5) 2 (12.5) 16 (11.0)
All 75 (54.3) 55 (39,9) 8 (5.8) 138 (100)
:|: A catheter was defined as central when the tip was in the innominate 
vein, the superior/inferior caval vein, or the right atrial cavity. When the 
tip was in the subclavian or common iliac vein it was defined as semic en­
tail.
T abus IV
Reasons for catheter removal (n =  130)
Number of removals %
Death of the newborn 24 18.5
Elective 34 26.2
Minor complications
Obstruction 5 3.8
Thrombophlebitis 26 20.0
Extravasation 22 16.9
Dislocation 7 5.4
Fluid leak 8 6.2
Major complications
Thrombosis 1 0.8
Perforation 2 1.5
Catheter-related sepsis 1 0.8
a combination of microorganisms: Enterobacter cloacae, 
Acinetobacter anitratum) and Citrobacter freundii. These 
same organisms were also found in the spinal fluid.
Six other tips revealed growth in the routine culture. 
They were considered tip colonization because no signs 
of infection (increased number of band neutrophils and 
total white blood count, unstable temperature, or positive 
blood culture) were apparent. The organisms involved 
were Candida (once), Staphylococcus aureus (once), and 
Staphylococcus epidermidis (four times).
DISCUSSION
The introduction of hydrophilic polyurethane catheters 
by means of the Seldinger technique resulted in a  high 
rate of adequately positioned catheters (94.2%), despite 
the low birth weight of the newborns. This might be 
due partly to the fact that the catheters were insetted
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by neonatologists. Furthermore, the time available for 
introduction was not limited, and if necessary, more 
insertion attempts were made (not registered). The 
overall procedure lasted between 30 and 90 minutes.
Other investigators who used peripheral veins for the 
percutaneous insertion of Silastic central venous cathe­
ters in newborns showed lower success rates in reaching 
a central position: Sherman et al (74%),20 Filston and 
Johnson (75%),27 Woods et al (79%),28 Puntis (84%),7 
and Dolcourt and Bose (88%).3 These rates would have 
been higher if semicentrally placed catheters also had 
been taken into account, eg, Woods et al (94%),28 Durand 
et al (96%),6 Hoekstra (93%),9 and Chathas et al(91%).10
The high number of semicentrally placed catheters in 
our study is due to  the restricted length of the 22-gauge 
central venous catheter, which might be too short when 
the greater saphenous vein is used and in newborns 
weighing more than 2500 g. The use of the 20-cm-long, 
20-gauge catheter in newborns weighing more than 2500 
g always resulted in a central position. The arbitrary 
limit of 2500 g seems adequate when determining whether 
to use the 20-gauge or the 22-gauge catheter. However, 
estimated measurement before catheter insertion is more 
appropriate. The number of catheter tips placed in a 
central position would have been higher if different 
lengths of the 22-gauge catheter had been available. 
This problem is avoided by the introduction of a 22-gauge 
hydrophilic polyurethane catheter with a length of 20 
cm.
Unlimited infusion management was achieved because 
of the large internal diameter of the central venous 
catheter. Although red-cell concentrates were occasion­
ally infused through them, the number of occluded 
catheters remained at an acceptable level. This might 
be due to the use of heparin29 and the continuous flow 
maintained by the infusion pumps.
The central venous catheter was also used for 
medication and hyperosmolar1 infusates. Complications 
caused by microparticulates, contamination,30 or chemi­
cal irritation can occur, especially when a greater part 
of the blood flow is obstructed and when relatively 
small semicentral veins are used. These effects might 
also be attributed to more intense mechanical irritation. 
Associated side effects are typically seen in low-birth- 
weight newborns such as those in our study.
Our mean duration of catheter use was short compared 
with the results of other studies in which peripheral 
veins were used for the percutaneous insertion of central 
venous catheters.3“10 The high overall rate of complica­
tions was also rather disappointing. It should be noted, 
however, that most complications were minor mechanical 
ones and did not necessitate therapeutic intervention. 
The knowledge that these complications can develop 
into more serious ones has led to more cautious catheter 
care. Consequently, catheters were removed sooner, 
even within a few hours after their insertion. A duration 
of zero days was noted in one case. In none of the 
other studies were such short durations registered.
The relatively large caliber of our catheter, the weight 
of the newborns, and the type of infusates contributed 
to the high rate of complications. Furthermore, severely
compromised newborns are more sensitive to compli­
cations.8 The severity of illness was not registered in 
our study. However, the high mortality rate, which was 
not catheter-related, reflects the vulnerability of new­
borns! It also had a negative effect on the mean duration
of catheter use.
The higher initial stiffness14,31 of the catheter, combined 
with the use of a guide wire, might cause vascular 
erosion along the vein during insertion, which is also 
a potential source of complications as reflected by the 
relatively high incidence of thrombophlebitis and ex­
travasation. The disadvantages of a more manipulative 
insertion might negate the beneficial effects of a smaller 
venipuncture site.
Our overall rate of serious mechanical and infectious 
complications (3.1%) is acceptable and seems compa­
rable to that seen by others (1.4% to 23,2%). The 
frequency of perforation (1.5%), a seldom seen compli­
cation, is rather high. This might also be a result of 
the more manipulative introduction technique and the 
stiffness of the catheter in use .32 Thrombosis, which 
occurs more often than clinical signs indicate, was the 
reason for catheter removal just once (0.8%). Although 
thrombosis was seen five times (3.8%), our rate seems 
comparable to that of others (0% to 1.6%). The higher 
detection rate, attributable to the routine ultrasonogra­
phy, must therefore be taken into account.
The incidence of catheter-related sepsis (0.8%) is low 
compared with other studies (0% to 12.5%), Colonization 
of the tip, mostly with S. epidermidis, was seen six 
times; the poor adherence of staphylococci to hydrophilic 
polyurethane catheters might be the cause .15 Our 
infection rate does not support the suggestion that 
operating room facilities are needed when the Seldinger 
technique is used .33
In conclusion, the use of the Seldinger technique in 
combination with a hydrophilic polyurethane catheter 
results in acceptable catheter tip placement, and it is 
a  suitable alternative for central venous catheterization 
in newborns. Although their use is accompanied by a 
high incidence of minor mechanical complications, the 
rate of major mechanical and infectious complications 
remains at an acceptable level. Compared with previous 
results with Silastic catheters, the mean catheter duration 
of 8.3 days is rather disappointing; however, it seems 
sufficient for the period of parenteral nutrition that is 
needed for preterm newborns.
We thank Mrs S. Houston for her linguistic support.
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